nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—COMT—prostate cancer	0.424	1	CbGaD
Entacapone—COMT—Conjugated Estrogens—prostate cancer	0.291	1	CbGbCtD
Entacapone—Tolcapone—COMT—prostate cancer	0.00292	1	CrCbGaD
Entacapone—UGT1A9—renal system—prostate cancer	0.00115	0.218	CbGeAlD
Entacapone—COMT—prostate gland—prostate cancer	0.000928	0.175	CbGeAlD
Entacapone—COMT—seminal vesicle—prostate cancer	0.000785	0.148	CbGeAlD
Entacapone—COMT—renal system—prostate cancer	0.000633	0.119	CbGeAlD
Entacapone—COMT—urethra—prostate cancer	0.000621	0.117	CbGeAlD
Entacapone—COMT—bone marrow—prostate cancer	0.000478	0.0902	CbGeAlD
Entacapone—COMT—testis—prostate cancer	0.000409	0.0771	CbGeAlD
Entacapone—COMT—lymph node—prostate cancer	0.000296	0.0559	CbGeAlD
Entacapone—COMT—Metabolism—GSTM3—prostate cancer	6.77e-05	0.000678	CbGpPWpGaD
Entacapone—COMT—Metabolism—SULT2B1—prostate cancer	6.77e-05	0.000678	CbGpPWpGaD
Entacapone—COMT—Metabolism—PGAM2—prostate cancer	6.77e-05	0.000678	CbGpPWpGaD
Entacapone—COMT—Metabolism—MBTPS1—prostate cancer	6.77e-05	0.000678	CbGpPWpGaD
Entacapone—COMT—Metabolism—AOX1—prostate cancer	6.77e-05	0.000678	CbGpPWpGaD
Entacapone—COMT—Metabolism—RFK—prostate cancer	6.77e-05	0.000678	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	6.71e-05	0.000673	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—prostate cancer	6.66e-05	0.000667	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—COMT—prostate cancer	6.65e-05	0.000666	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTP1—prostate cancer	6.62e-05	0.000663	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—COMT—prostate cancer	6.56e-05	0.000657	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	6.54e-05	0.000656	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTP1—prostate cancer	6.53e-05	0.000654	CbGpPWpGaD
Entacapone—COMT—Metabolism—AMACR—prostate cancer	6.42e-05	0.000643	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP3A43—prostate cancer	6.42e-05	0.000643	CbGpPWpGaD
Entacapone—COMT—Metabolism—SRD5A2—prostate cancer	6.42e-05	0.000643	CbGpPWpGaD
Entacapone—COMT—Metabolism—DEGS1—prostate cancer	6.42e-05	0.000643	CbGpPWpGaD
Entacapone—COMT—Metabolism—NAT1—prostate cancer	6.42e-05	0.000643	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	6.24e-05	0.000625	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	6.24e-05	0.000625	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD17B1—prostate cancer	6.12e-05	0.000613	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTM1—prostate cancer	6.08e-05	0.00061	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—prostate cancer	6e-05	0.000601	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CREBBP—prostate cancer	5.99e-05	0.0006	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—prostate cancer	5.86e-05	0.000587	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP1A1—prostate cancer	5.77e-05	0.000578	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HAO1—prostate cancer	5.69e-05	0.00057	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1A1—prostate cancer	5.69e-05	0.00057	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—prostate cancer	5.56e-05	0.000557	CbGpPWpGaD
Entacapone—COMT—Metabolism—HPGD—prostate cancer	5.46e-05	0.000547	CbGpPWpGaD
Entacapone—COMT—Metabolism—B4GALT4—prostate cancer	5.46e-05	0.000547	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	5.31e-05	0.000532	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—MDM2—prostate cancer	5.26e-05	0.000527	CbGpPWpGaD
Entacapone—COMT—Metabolism—TNFRSF21—prostate cancer	5.13e-05	0.000514	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	5.09e-05	0.00051	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—prostate cancer	5.09e-05	0.00051	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP7B1—prostate cancer	4.99e-05	0.0005	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTAP—prostate cancer	4.99e-05	0.0005	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	4.9e-05	0.000491	CbGpPWpGaD
Entacapone—COMT—Metabolism—SULT1E1—prostate cancer	4.86e-05	0.000487	CbGpPWpGaD
Entacapone—COMT—Metabolism—SRD5A1—prostate cancer	4.86e-05	0.000487	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	4.73e-05	0.000474	CbGpPWpGaD
Entacapone—COMT—Metabolism—ACSL4—prostate cancer	4.64e-05	0.000465	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ADI1—prostate cancer	4.64e-05	0.000465	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CBR1—prostate cancer	4.64e-05	0.000465	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GRHL1—prostate cancer	4.64e-05	0.000465	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD17B3—prostate cancer	4.64e-05	0.000465	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TST—prostate cancer	4.64e-05	0.000465	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PSAT1—prostate cancer	4.64e-05	0.000465	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CSAD—prostate cancer	4.64e-05	0.000465	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	4.53e-05	0.000454	CbGpPWpGaD
Entacapone—COMT—Metabolism—PHGDH—prostate cancer	4.45e-05	0.000446	CbGpPWpGaD
Entacapone—COMT—Metabolism—UMPS—prostate cancer	4.45e-05	0.000446	CbGpPWpGaD
Entacapone—COMT—Metabolism—ARG2—prostate cancer	4.45e-05	0.000446	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	4.45e-05	0.000446	CbGpPWpGaD
Entacapone—COMT—Metabolism—LDHB—prostate cancer	4.36e-05	0.000437	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CKMT2—prostate cancer	4.31e-05	0.000432	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GRHPR—prostate cancer	4.31e-05	0.000432	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UGT2B17—prostate cancer	4.31e-05	0.000432	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UGT2B15—prostate cancer	4.31e-05	0.000432	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP3A5—prostate cancer	4.28e-05	0.000429	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	4.22e-05	0.000422	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	4.15e-05	0.000416	CbGpPWpGaD
Entacapone—COMT—Metabolism—UCP3—prostate cancer	4.14e-05	0.000414	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA3—prostate cancer	4.14e-05	0.000414	CbGpPWpGaD
Entacapone—COMT—Metabolism—TCN2—prostate cancer	4.14e-05	0.000414	CbGpPWpGaD
Entacapone—COMT—Metabolism—PDHA1—prostate cancer	4.14e-05	0.000414	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—EP300—prostate cancer	4.08e-05	0.000409	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AOX1—prostate cancer	4.06e-05	0.000406	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SULT2B1—prostate cancer	4.06e-05	0.000406	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM3—prostate cancer	4.06e-05	0.000406	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PGAM2—prostate cancer	4.06e-05	0.000406	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NAGLU—prostate cancer	4.06e-05	0.000406	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—RFK—prostate cancer	4.06e-05	0.000406	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MBTPS1—prostate cancer	4.06e-05	0.000406	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—prostate cancer	4.04e-05	0.000405	CbGpPWpGaD
Entacapone—COMT—Neuronal System—MDM2—prostate cancer	4.03e-05	0.000404	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—prostate cancer	3.99e-05	0.0004	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.96e-05	0.000397	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD3B1—prostate cancer	3.94e-05	0.000395	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC22A3—prostate cancer	3.94e-05	0.000395	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AMACR—prostate cancer	3.84e-05	0.000385	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP3A43—prostate cancer	3.84e-05	0.000385	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SRD5A2—prostate cancer	3.84e-05	0.000385	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NAT1—prostate cancer	3.84e-05	0.000385	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—DEGS1—prostate cancer	3.84e-05	0.000385	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA4—prostate cancer	3.78e-05	0.000379	CbGpPWpGaD
Entacapone—COMT—Metabolism—TBXAS1—prostate cancer	3.78e-05	0.000379	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.78e-05	0.000379	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	3.76e-05	0.000377	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA2—prostate cancer	3.69e-05	0.000369	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD17B1—prostate cancer	3.67e-05	0.000367	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.67e-05	0.000367	CbGpPWpGaD
Entacapone—COMT—Metabolism—SULT1A1—prostate cancer	3.64e-05	0.000365	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCG5—prostate cancer	3.64e-05	0.000365	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA1—prostate cancer	3.56e-05	0.000356	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.53e-05	0.000353	CbGpPWpGaD
Entacapone—COMT—Metabolism—NAT2—prostate cancer	3.52e-05	0.000352	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTO1—prostate cancer	3.52e-05	0.000352	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD3B2—prostate cancer	3.52e-05	0.000352	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.51e-05	0.000352	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.47e-05	0.000348	CbGpPWpGaD
Entacapone—COMT—Metabolism—PLCB2—prostate cancer	3.37e-05	0.000338	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2C18—prostate cancer	3.37e-05	0.000338	CbGpPWpGaD
Entacapone—COMT—Metabolism—LRP2—prostate cancer	3.37e-05	0.000338	CbGpPWpGaD
Entacapone—Urethral disorder—Epirubicin—prostate cancer	3.35e-05	0.000189	CcSEcCtD
Entacapone—Loss of consciousness—Prednisone—prostate cancer	3.34e-05	0.000189	CcSEcCtD
Entacapone—Hepatobiliary disease—Doxorubicin—prostate cancer	3.33e-05	0.000188	CcSEcCtD
Entacapone—Epistaxis—Doxorubicin—prostate cancer	3.32e-05	0.000187	CcSEcCtD
Entacapone—Anorexia—Capecitabine—prostate cancer	3.32e-05	0.000187	CcSEcCtD
Entacapone—Nausea—Estradiol—prostate cancer	3.32e-05	0.000187	CcSEcCtD
Entacapone—Vomiting—Mitoxantrone—prostate cancer	3.31e-05	0.000187	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3.31e-05	0.000331	CbGpPWpGaD
Entacapone—COMT—Metabolism—P4HB—prostate cancer	3.31e-05	0.000331	CbGpPWpGaD
Entacapone—Sinusitis—Doxorubicin—prostate cancer	3.3e-05	0.000186	CcSEcCtD
Entacapone—Convulsion—Prednisone—prostate cancer	3.29e-05	0.000186	CcSEcCtD
Entacapone—Visual impairment—Epirubicin—prostate cancer	3.29e-05	0.000186	CcSEcCtD
Entacapone—Agranulocytosis—Doxorubicin—prostate cancer	3.28e-05	0.000185	CcSEcCtD
Entacapone—Hypertension—Prednisone—prostate cancer	3.28e-05	0.000185	CcSEcCtD
Entacapone—Rash—Mitoxantrone—prostate cancer	3.28e-05	0.000185	CcSEcCtD
Entacapone—Dermatitis—Mitoxantrone—prostate cancer	3.28e-05	0.000185	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.28e-05	0.000185	CcSEcCtD
Entacapone—UGT1A9—Metabolism—HPGD—prostate cancer	3.27e-05	0.000328	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—B4GALT4—prostate cancer	3.27e-05	0.000328	CbGpPWpGaD
Entacapone—Headache—Mitoxantrone—prostate cancer	3.26e-05	0.000184	CcSEcCtD
Entacapone—Hypotension—Capecitabine—prostate cancer	3.25e-05	0.000184	CcSEcCtD
Entacapone—Insomnia—Docetaxel—prostate cancer	3.25e-05	0.000184	CcSEcCtD
Entacapone—Myalgia—Prednisone—prostate cancer	3.24e-05	0.000183	CcSEcCtD
Entacapone—Paraesthesia—Docetaxel—prostate cancer	3.23e-05	0.000182	CcSEcCtD
Entacapone—Erythema multiforme—Epirubicin—prostate cancer	3.23e-05	0.000182	CcSEcCtD
Entacapone—Anxiety—Prednisone—prostate cancer	3.22e-05	0.000182	CcSEcCtD
Entacapone—Bradycardia—Doxorubicin—prostate cancer	3.22e-05	0.000182	CcSEcCtD
Entacapone—COMT—Metabolism—SLC22A1—prostate cancer	3.22e-05	0.000322	CbGpPWpGaD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.21e-05	0.000181	CcSEcCtD
Entacapone—Dyspnoea—Docetaxel—prostate cancer	3.21e-05	0.000181	CcSEcCtD
Entacapone—Somnolence—Docetaxel—prostate cancer	3.2e-05	0.000181	CcSEcCtD
Entacapone—Discomfort—Prednisone—prostate cancer	3.2e-05	0.00018	CcSEcCtD
Entacapone—Eye disorder—Epirubicin—prostate cancer	3.19e-05	0.00018	CcSEcCtD
Entacapone—Hypersensitivity—Etoposide—prostate cancer	3.19e-05	0.00018	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—prostate cancer	3.18e-05	0.000179	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.17e-05	0.000179	CcSEcCtD
Entacapone—Flushing—Epirubicin—prostate cancer	3.17e-05	0.000179	CcSEcCtD
Entacapone—Cardiac disorder—Epirubicin—prostate cancer	3.17e-05	0.000179	CcSEcCtD
Entacapone—Dyspepsia—Docetaxel—prostate cancer	3.17e-05	0.000179	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—prostate cancer	3.16e-05	0.000178	CcSEcCtD
Entacapone—Hepatitis—Doxorubicin—prostate cancer	3.16e-05	0.000178	CcSEcCtD
Entacapone—Insomnia—Capecitabine—prostate cancer	3.15e-05	0.000178	CcSEcCtD
Entacapone—Hypoaesthesia—Doxorubicin—prostate cancer	3.14e-05	0.000177	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—prostate cancer	3.14e-05	0.000177	CcSEcCtD
Entacapone—COMT—Metabolism—SULT2A1—prostate cancer	3.13e-05	0.000314	CbGpPWpGaD
Entacapone—Paraesthesia—Capecitabine—prostate cancer	3.13e-05	0.000177	CcSEcCtD
Entacapone—Decreased appetite—Docetaxel—prostate cancer	3.13e-05	0.000177	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—prostate cancer	3.12e-05	0.000176	CcSEcCtD
Entacapone—Gastrointestinal disorder—Docetaxel—prostate cancer	3.11e-05	0.000175	CcSEcCtD
Entacapone—Asthenia—Etoposide—prostate cancer	3.11e-05	0.000175	CcSEcCtD
Entacapone—Dyspnoea—Capecitabine—prostate cancer	3.1e-05	0.000175	CcSEcCtD
Entacapone—Oedema—Prednisone—prostate cancer	3.1e-05	0.000175	CcSEcCtD
Entacapone—Fatigue—Docetaxel—prostate cancer	3.1e-05	0.000175	CcSEcCtD
Entacapone—Urethral disorder—Doxorubicin—prostate cancer	3.1e-05	0.000175	CcSEcCtD
Entacapone—Nausea—Mitoxantrone—prostate cancer	3.09e-05	0.000174	CcSEcCtD
Entacapone—COMT—Metabolism—MED12—prostate cancer	3.08e-05	0.000309	CbGpPWpGaD
Entacapone—Pain—Docetaxel—prostate cancer	3.08e-05	0.000174	CcSEcCtD
Entacapone—Constipation—Docetaxel—prostate cancer	3.08e-05	0.000174	CcSEcCtD
Entacapone—UGT1A9—Metabolism—TNFRSF21—prostate cancer	3.07e-05	0.000308	CbGpPWpGaD
Entacapone—Dyspepsia—Capecitabine—prostate cancer	3.07e-05	0.000173	CcSEcCtD
Entacapone—Pruritus—Etoposide—prostate cancer	3.06e-05	0.000173	CcSEcCtD
Entacapone—COMT—Metabolism—GNG5—prostate cancer	3.06e-05	0.000307	CbGpPWpGaD
Entacapone—Shock—Prednisone—prostate cancer	3.05e-05	0.000172	CcSEcCtD
Entacapone—Visual impairment—Doxorubicin—prostate cancer	3.04e-05	0.000172	CcSEcCtD
Entacapone—Nervous system disorder—Prednisone—prostate cancer	3.04e-05	0.000172	CcSEcCtD
Entacapone—Decreased appetite—Capecitabine—prostate cancer	3.03e-05	0.000171	CcSEcCtD
Entacapone—Alopecia—Epirubicin—prostate cancer	3.02e-05	0.00017	CcSEcCtD
Entacapone—Skin disorder—Prednisone—prostate cancer	3.01e-05	0.00017	CcSEcCtD
Entacapone—Gastrointestinal disorder—Capecitabine—prostate cancer	3.01e-05	0.00017	CcSEcCtD
Entacapone—Fatigue—Capecitabine—prostate cancer	3e-05	0.000169	CcSEcCtD
Entacapone—Hyperhidrosis—Prednisone—prostate cancer	3e-05	0.000169	CcSEcCtD
Entacapone—Mental disorder—Epirubicin—prostate cancer	2.99e-05	0.000169	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP7B1—prostate cancer	2.99e-05	0.0003	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTAP—prostate cancer	2.99e-05	0.0003	CbGpPWpGaD
Entacapone—Erythema multiforme—Doxorubicin—prostate cancer	2.99e-05	0.000169	CcSEcCtD
Entacapone—Constipation—Capecitabine—prostate cancer	2.98e-05	0.000168	CcSEcCtD
Entacapone—Pain—Capecitabine—prostate cancer	2.98e-05	0.000168	CcSEcCtD
Entacapone—Malnutrition—Epirubicin—prostate cancer	2.97e-05	0.000168	CcSEcCtD
Entacapone—Feeling abnormal—Docetaxel—prostate cancer	2.96e-05	0.000167	CcSEcCtD
Entacapone—Diarrhoea—Etoposide—prostate cancer	2.96e-05	0.000167	CcSEcCtD
Entacapone—Anorexia—Prednisone—prostate cancer	2.96e-05	0.000167	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—prostate cancer	2.95e-05	0.000167	CcSEcCtD
Entacapone—COMT—Metabolism—NCOA3—prostate cancer	2.95e-05	0.000295	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Docetaxel—prostate cancer	2.94e-05	0.000166	CcSEcCtD
Entacapone—Flushing—Doxorubicin—prostate cancer	2.93e-05	0.000166	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—prostate cancer	2.93e-05	0.000166	CcSEcCtD
Entacapone—Flatulence—Epirubicin—prostate cancer	2.93e-05	0.000165	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.92e-05	0.000293	CbGpPWpGaD
Entacapone—Tension—Epirubicin—prostate cancer	2.92e-05	0.000165	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SULT1E1—prostate cancer	2.91e-05	0.000292	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SRD5A1—prostate cancer	2.91e-05	0.000292	CbGpPWpGaD
Entacapone—Dysgeusia—Epirubicin—prostate cancer	2.91e-05	0.000164	CcSEcCtD
Entacapone—Nervousness—Epirubicin—prostate cancer	2.89e-05	0.000163	CcSEcCtD
Entacapone—Back pain—Epirubicin—prostate cancer	2.88e-05	0.000162	CcSEcCtD
Entacapone—Feeling abnormal—Capecitabine—prostate cancer	2.87e-05	0.000162	CcSEcCtD
Entacapone—Dizziness—Etoposide—prostate cancer	2.86e-05	0.000162	CcSEcCtD
Entacapone—Muscle spasms—Epirubicin—prostate cancer	2.86e-05	0.000161	CcSEcCtD
Entacapone—Gastrointestinal pain—Capecitabine—prostate cancer	2.85e-05	0.000161	CcSEcCtD
Entacapone—Body temperature increased—Docetaxel—prostate cancer	2.84e-05	0.000161	CcSEcCtD
Entacapone—Abdominal pain—Docetaxel—prostate cancer	2.84e-05	0.000161	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.83e-05	0.000284	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFB1—prostate cancer	2.83e-05	0.000283	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Prednisone—prostate cancer	2.83e-05	0.00016	CcSEcCtD
Entacapone—COMT—Metabolism—HPGDS—prostate cancer	2.81e-05	0.000282	CbGpPWpGaD
Entacapone—Insomnia—Prednisone—prostate cancer	2.81e-05	0.000158	CcSEcCtD
Entacapone—Vision blurred—Epirubicin—prostate cancer	2.8e-05	0.000158	CcSEcCtD
Entacapone—COMT—Metabolism—CYP2C19—prostate cancer	2.79e-05	0.00028	CbGpPWpGaD
Entacapone—Alopecia—Doxorubicin—prostate cancer	2.79e-05	0.000158	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.79e-05	0.000279	CbGpPWpGaD
Entacapone—Paraesthesia—Prednisone—prostate cancer	2.79e-05	0.000157	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ACSL4—prostate cancer	2.78e-05	0.000279	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD17B3—prostate cancer	2.78e-05	0.000279	CbGpPWpGaD
Entacapone—Mental disorder—Doxorubicin—prostate cancer	2.77e-05	0.000156	CcSEcCtD
Entacapone—Urticaria—Capecitabine—prostate cancer	2.77e-05	0.000156	CcSEcCtD
Entacapone—Ill-defined disorder—Epirubicin—prostate cancer	2.76e-05	0.000156	CcSEcCtD
Entacapone—Body temperature increased—Capecitabine—prostate cancer	2.75e-05	0.000155	CcSEcCtD
Entacapone—Abdominal pain—Capecitabine—prostate cancer	2.75e-05	0.000155	CcSEcCtD
Entacapone—Vomiting—Etoposide—prostate cancer	2.75e-05	0.000155	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—prostate cancer	2.75e-05	0.000276	CbGpPWpGaD
Entacapone—Malnutrition—Doxorubicin—prostate cancer	2.75e-05	0.000155	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.75e-05	0.000275	CbGpPWpGaD
Entacapone—Agitation—Epirubicin—prostate cancer	2.73e-05	0.000154	CcSEcCtD
Entacapone—Dyspepsia—Prednisone—prostate cancer	2.73e-05	0.000154	CcSEcCtD
Entacapone—Rash—Etoposide—prostate cancer	2.73e-05	0.000154	CcSEcCtD
Entacapone—COMT—Metabolism—GSTT1—prostate cancer	2.73e-05	0.000273	CbGpPWpGaD
Entacapone—COMT—Metabolism—ACHE—prostate cancer	2.73e-05	0.000273	CbGpPWpGaD
Entacapone—Dermatitis—Etoposide—prostate cancer	2.73e-05	0.000154	CcSEcCtD
Entacapone—Headache—Etoposide—prostate cancer	2.71e-05	0.000153	CcSEcCtD
Entacapone—Flatulence—Doxorubicin—prostate cancer	2.71e-05	0.000153	CcSEcCtD
Entacapone—Tension—Doxorubicin—prostate cancer	2.7e-05	0.000152	CcSEcCtD
Entacapone—Decreased appetite—Prednisone—prostate cancer	2.7e-05	0.000152	CcSEcCtD
Entacapone—COMT—Metabolism—CYP2A6—prostate cancer	2.69e-05	0.00027	CbGpPWpGaD
Entacapone—Dysgeusia—Doxorubicin—prostate cancer	2.69e-05	0.000152	CcSEcCtD
Entacapone—Malaise—Epirubicin—prostate cancer	2.68e-05	0.000151	CcSEcCtD
Entacapone—Fatigue—Prednisone—prostate cancer	2.67e-05	0.000151	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—prostate cancer	2.67e-05	0.000151	CcSEcCtD
Entacapone—Vertigo—Epirubicin—prostate cancer	2.67e-05	0.000151	CcSEcCtD
Entacapone—Syncope—Epirubicin—prostate cancer	2.67e-05	0.00015	CcSEcCtD
Entacapone—UGT1A9—Metabolism—UMPS—prostate cancer	2.66e-05	0.000267	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PHGDH—prostate cancer	2.66e-05	0.000267	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ARG2—prostate cancer	2.66e-05	0.000267	CbGpPWpGaD
Entacapone—Leukopenia—Epirubicin—prostate cancer	2.66e-05	0.00015	CcSEcCtD
Entacapone—Back pain—Doxorubicin—prostate cancer	2.66e-05	0.00015	CcSEcCtD
Entacapone—Constipation—Prednisone—prostate cancer	2.65e-05	0.00015	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.65e-05	0.000266	CbGpPWpGaD
Entacapone—Hypersensitivity—Docetaxel—prostate cancer	2.65e-05	0.00015	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—prostate cancer	2.64e-05	0.000149	CcSEcCtD
Entacapone—Palpitations—Epirubicin—prostate cancer	2.63e-05	0.000148	CcSEcCtD
Entacapone—COMT—Metabolism—AKR1C3—prostate cancer	2.62e-05	0.000263	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LDHB—prostate cancer	2.61e-05	0.000262	CbGpPWpGaD
Entacapone—Loss of consciousness—Epirubicin—prostate cancer	2.61e-05	0.000147	CcSEcCtD
Entacapone—COMT—Metabolism—PRKACB—prostate cancer	2.61e-05	0.000261	CbGpPWpGaD
Entacapone—Cough—Epirubicin—prostate cancer	2.59e-05	0.000146	CcSEcCtD
Entacapone—Vision blurred—Doxorubicin—prostate cancer	2.59e-05	0.000146	CcSEcCtD
Entacapone—COMT—Metabolism—CYP17A1—prostate cancer	2.58e-05	0.000259	CbGpPWpGaD
Entacapone—Asthenia—Docetaxel—prostate cancer	2.58e-05	0.000146	CcSEcCtD
Entacapone—Convulsion—Epirubicin—prostate cancer	2.58e-05	0.000145	CcSEcCtD
Entacapone—Nausea—Etoposide—prostate cancer	2.57e-05	0.000145	CcSEcCtD
Entacapone—Hypertension—Epirubicin—prostate cancer	2.57e-05	0.000145	CcSEcCtD
Entacapone—Hypersensitivity—Capecitabine—prostate cancer	2.57e-05	0.000145	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP3A5—prostate cancer	2.57e-05	0.000257	CbGpPWpGaD
Entacapone—Feeling abnormal—Prednisone—prostate cancer	2.56e-05	0.000144	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—prostate cancer	2.55e-05	0.000144	CcSEcCtD
Entacapone—Pruritus—Docetaxel—prostate cancer	2.54e-05	0.000144	CcSEcCtD
Entacapone—Gastrointestinal pain—Prednisone—prostate cancer	2.54e-05	0.000143	CcSEcCtD
Entacapone—Chest pain—Epirubicin—prostate cancer	2.53e-05	0.000143	CcSEcCtD
Entacapone—Myalgia—Epirubicin—prostate cancer	2.53e-05	0.000143	CcSEcCtD
Entacapone—Agitation—Doxorubicin—prostate cancer	2.53e-05	0.000143	CcSEcCtD
Entacapone—Anxiety—Epirubicin—prostate cancer	2.52e-05	0.000142	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.51e-05	0.000142	CcSEcCtD
Entacapone—Discomfort—Epirubicin—prostate cancer	2.5e-05	0.000141	CcSEcCtD
Entacapone—Asthenia—Capecitabine—prostate cancer	2.5e-05	0.000141	CcSEcCtD
Entacapone—Malaise—Doxorubicin—prostate cancer	2.48e-05	0.00014	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PDHA1—prostate cancer	2.48e-05	0.000248	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TCN2—prostate cancer	2.48e-05	0.000248	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UCP3—prostate cancer	2.48e-05	0.000248	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTA3—prostate cancer	2.48e-05	0.000248	CbGpPWpGaD
Entacapone—Dry mouth—Epirubicin—prostate cancer	2.47e-05	0.00014	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—prostate cancer	2.47e-05	0.00014	CcSEcCtD
Entacapone—Syncope—Doxorubicin—prostate cancer	2.47e-05	0.000139	CcSEcCtD
Entacapone—Urticaria—Prednisone—prostate cancer	2.46e-05	0.000139	CcSEcCtD
Entacapone—Pruritus—Capecitabine—prostate cancer	2.46e-05	0.000139	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—prostate cancer	2.46e-05	0.000139	CcSEcCtD
Entacapone—Diarrhoea—Docetaxel—prostate cancer	2.46e-05	0.000139	CcSEcCtD
Entacapone—COMT—Metabolism—NCOA2—prostate cancer	2.46e-05	0.000246	CbGpPWpGaD
Entacapone—Abdominal pain—Prednisone—prostate cancer	2.45e-05	0.000138	CcSEcCtD
Entacapone—Body temperature increased—Prednisone—prostate cancer	2.45e-05	0.000138	CcSEcCtD
Entacapone—Confusional state—Epirubicin—prostate cancer	2.45e-05	0.000138	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—prostate cancer	2.43e-05	0.000137	CcSEcCtD
Entacapone—Oedema—Epirubicin—prostate cancer	2.43e-05	0.000137	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—prostate cancer	2.42e-05	0.000136	CcSEcCtD
Entacapone—Cough—Doxorubicin—prostate cancer	2.4e-05	0.000135	CcSEcCtD
Entacapone—Shock—Epirubicin—prostate cancer	2.39e-05	0.000135	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—prostate cancer	2.38e-05	0.000135	CcSEcCtD
Entacapone—Diarrhoea—Capecitabine—prostate cancer	2.38e-05	0.000135	CcSEcCtD
Entacapone—Nervous system disorder—Epirubicin—prostate cancer	2.38e-05	0.000134	CcSEcCtD
Entacapone—Dizziness—Docetaxel—prostate cancer	2.38e-05	0.000134	CcSEcCtD
Entacapone—Thrombocytopenia—Epirubicin—prostate cancer	2.38e-05	0.000134	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—prostate cancer	2.37e-05	0.000134	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SLC22A3—prostate cancer	2.36e-05	0.000237	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD3B1—prostate cancer	2.36e-05	0.000237	CbGpPWpGaD
Entacapone—Skin disorder—Epirubicin—prostate cancer	2.36e-05	0.000133	CcSEcCtD
Entacapone—COMT—Metabolism—SLC5A5—prostate cancer	2.35e-05	0.000235	CbGpPWpGaD
Entacapone—Hyperhidrosis—Epirubicin—prostate cancer	2.35e-05	0.000132	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—prostate cancer	2.34e-05	0.000132	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—prostate cancer	2.34e-05	0.000132	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—prostate cancer	2.33e-05	0.000132	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.33e-05	0.000131	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—prostate cancer	2.31e-05	0.000131	CcSEcCtD
Entacapone—Anorexia—Epirubicin—prostate cancer	2.31e-05	0.000131	CcSEcCtD
Entacapone—Dizziness—Capecitabine—prostate cancer	2.3e-05	0.00013	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.29e-05	0.00023	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2E1—prostate cancer	2.29e-05	0.00023	CbGpPWpGaD
Entacapone—Dry mouth—Doxorubicin—prostate cancer	2.29e-05	0.000129	CcSEcCtD
Entacapone—Vomiting—Docetaxel—prostate cancer	2.29e-05	0.000129	CcSEcCtD
Entacapone—Hypersensitivity—Prednisone—prostate cancer	2.29e-05	0.000129	CcSEcCtD
Entacapone—Rash—Docetaxel—prostate cancer	2.27e-05	0.000128	CcSEcCtD
Entacapone—Hypotension—Epirubicin—prostate cancer	2.27e-05	0.000128	CcSEcCtD
Entacapone—UGT1A9—Metabolism—TBXAS1—prostate cancer	2.27e-05	0.000227	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTA4—prostate cancer	2.27e-05	0.000227	CbGpPWpGaD
Entacapone—COMT—Metabolism—NQO1—prostate cancer	2.27e-05	0.000227	CbGpPWpGaD
Entacapone—Dermatitis—Docetaxel—prostate cancer	2.27e-05	0.000128	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—prostate cancer	2.26e-05	0.000128	CcSEcCtD
Entacapone—Headache—Docetaxel—prostate cancer	2.25e-05	0.000127	CcSEcCtD
Entacapone—Oedema—Doxorubicin—prostate cancer	2.24e-05	0.000127	CcSEcCtD
Entacapone—COMT—Metabolism—TH—prostate cancer	2.23e-05	0.000224	CbGpPWpGaD
Entacapone—Asthenia—Prednisone—prostate cancer	2.23e-05	0.000126	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.21e-05	0.000222	CbGpPWpGaD
Entacapone—Vomiting—Capecitabine—prostate cancer	2.21e-05	0.000125	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.21e-05	0.000125	CcSEcCtD
Entacapone—COMT—Metabolism—CYP3A4—prostate cancer	2.21e-05	0.000221	CbGpPWpGaD
Entacapone—Shock—Doxorubicin—prostate cancer	2.21e-05	0.000125	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GSTA2—prostate cancer	2.21e-05	0.000221	CbGpPWpGaD
Entacapone—Nervous system disorder—Doxorubicin—prostate cancer	2.2e-05	0.000124	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—prostate cancer	2.2e-05	0.000124	CcSEcCtD
Entacapone—Rash—Capecitabine—prostate cancer	2.2e-05	0.000124	CcSEcCtD
Entacapone—Pruritus—Prednisone—prostate cancer	2.19e-05	0.000124	CcSEcCtD
Entacapone—Insomnia—Epirubicin—prostate cancer	2.19e-05	0.000124	CcSEcCtD
Entacapone—Dermatitis—Capecitabine—prostate cancer	2.19e-05	0.000124	CcSEcCtD
Entacapone—Headache—Capecitabine—prostate cancer	2.18e-05	0.000123	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ABCG5—prostate cancer	2.18e-05	0.000219	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SULT1A1—prostate cancer	2.18e-05	0.000219	CbGpPWpGaD
Entacapone—Skin disorder—Doxorubicin—prostate cancer	2.18e-05	0.000123	CcSEcCtD
Entacapone—Paraesthesia—Epirubicin—prostate cancer	2.18e-05	0.000123	CcSEcCtD
Entacapone—COMT—Metabolism—CYP1B1—prostate cancer	2.17e-05	0.000218	CbGpPWpGaD
Entacapone—Hyperhidrosis—Doxorubicin—prostate cancer	2.17e-05	0.000123	CcSEcCtD
Entacapone—Dyspnoea—Epirubicin—prostate cancer	2.16e-05	0.000122	CcSEcCtD
Entacapone—Somnolence—Epirubicin—prostate cancer	2.16e-05	0.000122	CcSEcCtD
Entacapone—Anorexia—Doxorubicin—prostate cancer	2.14e-05	0.000121	CcSEcCtD
Entacapone—Nausea—Docetaxel—prostate cancer	2.14e-05	0.000121	CcSEcCtD
Entacapone—Dyspepsia—Epirubicin—prostate cancer	2.14e-05	0.000121	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GSTA1—prostate cancer	2.13e-05	0.000213	CbGpPWpGaD
Entacapone—Diarrhoea—Prednisone—prostate cancer	2.12e-05	0.00012	CcSEcCtD
Entacapone—Decreased appetite—Epirubicin—prostate cancer	2.11e-05	0.000119	CcSEcCtD
Entacapone—UGT1A9—Metabolism—HSD3B2—prostate cancer	2.11e-05	0.000211	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTO1—prostate cancer	2.11e-05	0.000211	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NAT2—prostate cancer	2.11e-05	0.000211	CbGpPWpGaD
Entacapone—COMT—Metabolism—GGT1—prostate cancer	2.1e-05	0.000211	CbGpPWpGaD
Entacapone—Hypotension—Doxorubicin—prostate cancer	2.1e-05	0.000118	CcSEcCtD
Entacapone—Gastrointestinal disorder—Epirubicin—prostate cancer	2.09e-05	0.000118	CcSEcCtD
Entacapone—Fatigue—Epirubicin—prostate cancer	2.09e-05	0.000118	CcSEcCtD
Entacapone—Constipation—Epirubicin—prostate cancer	2.07e-05	0.000117	CcSEcCtD
Entacapone—Pain—Epirubicin—prostate cancer	2.07e-05	0.000117	CcSEcCtD
Entacapone—COMT—Metabolism—NCOA1—prostate cancer	2.07e-05	0.000208	CbGpPWpGaD
Entacapone—Nausea—Capecitabine—prostate cancer	2.07e-05	0.000117	CcSEcCtD
Entacapone—Dizziness—Prednisone—prostate cancer	2.05e-05	0.000116	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.05e-05	0.000115	CcSEcCtD
Entacapone—COMT—Metabolism—CYP19A1—prostate cancer	2.04e-05	0.000205	CbGpPWpGaD
Entacapone—Insomnia—Doxorubicin—prostate cancer	2.03e-05	0.000115	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.03e-05	0.000203	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LRP2—prostate cancer	2.02e-05	0.000202	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2C18—prostate cancer	2.02e-05	0.000202	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLCB2—prostate cancer	2.02e-05	0.000202	CbGpPWpGaD
Entacapone—Paraesthesia—Doxorubicin—prostate cancer	2.02e-05	0.000114	CcSEcCtD
Entacapone—Dyspnoea—Doxorubicin—prostate cancer	2e-05	0.000113	CcSEcCtD
Entacapone—Feeling abnormal—Epirubicin—prostate cancer	2e-05	0.000113	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—prostate cancer	2e-05	0.000113	CcSEcCtD
Entacapone—Gastrointestinal pain—Epirubicin—prostate cancer	1.98e-05	0.000112	CcSEcCtD
Entacapone—UGT1A9—Metabolism—P4HB—prostate cancer	1.98e-05	0.000198	CbGpPWpGaD
Entacapone—Dyspepsia—Doxorubicin—prostate cancer	1.98e-05	0.000112	CcSEcCtD
Entacapone—Vomiting—Prednisone—prostate cancer	1.97e-05	0.000111	CcSEcCtD
Entacapone—COMT—Metabolism—RXRA—prostate cancer	1.97e-05	0.000198	CbGpPWpGaD
Entacapone—Rash—Prednisone—prostate cancer	1.96e-05	0.00011	CcSEcCtD
Entacapone—Dermatitis—Prednisone—prostate cancer	1.95e-05	0.00011	CcSEcCtD
Entacapone—Decreased appetite—Doxorubicin—prostate cancer	1.95e-05	0.00011	CcSEcCtD
Entacapone—Headache—Prednisone—prostate cancer	1.94e-05	0.00011	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.94e-05	0.000109	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—prostate cancer	1.94e-05	0.000109	CcSEcCtD
Entacapone—Urticaria—Epirubicin—prostate cancer	1.93e-05	0.000109	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SLC22A1—prostate cancer	1.93e-05	0.000193	CbGpPWpGaD
Entacapone—Pain—Doxorubicin—prostate cancer	1.92e-05	0.000108	CcSEcCtD
Entacapone—Constipation—Doxorubicin—prostate cancer	1.92e-05	0.000108	CcSEcCtD
Entacapone—Abdominal pain—Epirubicin—prostate cancer	1.92e-05	0.000108	CcSEcCtD
Entacapone—Body temperature increased—Epirubicin—prostate cancer	1.92e-05	0.000108	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.9e-05	0.000191	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTP1—prostate cancer	1.89e-05	0.000189	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SULT2A1—prostate cancer	1.88e-05	0.000188	CbGpPWpGaD
Entacapone—COMT—Metabolism—ITPR1—prostate cancer	1.86e-05	0.000186	CbGpPWpGaD
Entacapone—Feeling abnormal—Doxorubicin—prostate cancer	1.85e-05	0.000104	CcSEcCtD
Entacapone—UGT1A9—Metabolism—MED12—prostate cancer	1.85e-05	0.000185	CbGpPWpGaD
Entacapone—Nausea—Prednisone—prostate cancer	1.84e-05	0.000104	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—prostate cancer	1.84e-05	0.000104	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GNG5—prostate cancer	1.83e-05	0.000184	CbGpPWpGaD
Entacapone—Hypersensitivity—Epirubicin—prostate cancer	1.79e-05	0.000101	CcSEcCtD
Entacapone—Urticaria—Doxorubicin—prostate cancer	1.78e-05	0.000101	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—prostate cancer	1.77e-05	0.0001	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—prostate cancer	1.77e-05	0.0001	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NCOA3—prostate cancer	1.77e-05	0.000177	CbGpPWpGaD
Entacapone—COMT—Metabolism—TYMS—prostate cancer	1.76e-05	0.000176	CbGpPWpGaD
Entacapone—Asthenia—Epirubicin—prostate cancer	1.74e-05	9.83e-05	CcSEcCtD
Entacapone—COMT—Metabolism—GSTM1—prostate cancer	1.74e-05	0.000174	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.73e-05	0.000174	CbGpPWpGaD
Entacapone—Pruritus—Epirubicin—prostate cancer	1.72e-05	9.69e-05	CcSEcCtD
Entacapone—COMT—Metabolism—LPL—prostate cancer	1.7e-05	0.000171	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HPGDS—prostate cancer	1.68e-05	0.000169	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2C19—prostate cancer	1.67e-05	0.000168	CbGpPWpGaD
Entacapone—Diarrhoea—Epirubicin—prostate cancer	1.66e-05	9.37e-05	CcSEcCtD
Entacapone—Hypersensitivity—Doxorubicin—prostate cancer	1.65e-05	9.34e-05	CcSEcCtD
Entacapone—COMT—Metabolism—CYP1A1—prostate cancer	1.65e-05	0.000165	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTT1—prostate cancer	1.63e-05	0.000164	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ACHE—prostate cancer	1.63e-05	0.000164	CbGpPWpGaD
Entacapone—COMT—Metabolism—ERCC2—prostate cancer	1.63e-05	0.000164	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2A6—prostate cancer	1.61e-05	0.000162	CbGpPWpGaD
Entacapone—Asthenia—Doxorubicin—prostate cancer	1.61e-05	9.09e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.61e-05	0.000161	CbGpPWpGaD
Entacapone—Dizziness—Epirubicin—prostate cancer	1.6e-05	9.06e-05	CcSEcCtD
Entacapone—Pruritus—Doxorubicin—prostate cancer	1.59e-05	8.97e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—AKR1C3—prostate cancer	1.57e-05	0.000157	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PRKACB—prostate cancer	1.56e-05	0.000157	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP17A1—prostate cancer	1.55e-05	0.000155	CbGpPWpGaD
Entacapone—Vomiting—Epirubicin—prostate cancer	1.54e-05	8.71e-05	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—prostate cancer	1.54e-05	8.67e-05	CcSEcCtD
Entacapone—COMT—Metabolism—MTHFR—prostate cancer	1.53e-05	0.000154	CbGpPWpGaD
Entacapone—Rash—Epirubicin—prostate cancer	1.53e-05	8.64e-05	CcSEcCtD
Entacapone—Dermatitis—Epirubicin—prostate cancer	1.53e-05	8.63e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.52e-05	0.000153	CbGpPWpGaD
Entacapone—Headache—Epirubicin—prostate cancer	1.52e-05	8.58e-05	CcSEcCtD
Entacapone—COMT—Metabolism—PPARA—prostate cancer	1.51e-05	0.000151	CbGpPWpGaD
Entacapone—Dizziness—Doxorubicin—prostate cancer	1.48e-05	8.38e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NCOA2—prostate cancer	1.47e-05	0.000148	CbGpPWpGaD
Entacapone—Nausea—Epirubicin—prostate cancer	1.44e-05	8.14e-05	CcSEcCtD
Entacapone—Vomiting—Doxorubicin—prostate cancer	1.43e-05	8.06e-05	CcSEcCtD
Entacapone—COMT—Metabolism—CAV1—prostate cancer	1.42e-05	0.000142	CbGpPWpGaD
Entacapone—Rash—Doxorubicin—prostate cancer	1.42e-05	7.99e-05	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—prostate cancer	1.41e-05	7.98e-05	CcSEcCtD
Entacapone—Headache—Doxorubicin—prostate cancer	1.41e-05	7.94e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SLC5A5—prostate cancer	1.41e-05	0.000141	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2E1—prostate cancer	1.37e-05	0.000138	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NQO1—prostate cancer	1.36e-05	0.000136	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TH—prostate cancer	1.34e-05	0.000134	CbGpPWpGaD
Entacapone—Nausea—Doxorubicin—prostate cancer	1.33e-05	7.53e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.33e-05	0.000133	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP3A4—prostate cancer	1.32e-05	0.000133	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.32e-05	0.000132	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1B1—prostate cancer	1.3e-05	0.00013	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CG—prostate cancer	1.29e-05	0.000129	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GGT1—prostate cancer	1.26e-05	0.000126	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NCOA1—prostate cancer	1.24e-05	0.000124	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP19A1—prostate cancer	1.22e-05	0.000123	CbGpPWpGaD
Entacapone—COMT—Metabolism—INS—prostate cancer	1.22e-05	0.000122	CbGpPWpGaD
Entacapone—COMT—Metabolism—CREBBP—prostate cancer	1.2e-05	0.00012	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—RXRA—prostate cancer	1.18e-05	0.000118	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.15e-05	0.000115	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—COMT—prostate cancer	1.14e-05	0.000114	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CD—prostate cancer	1.13e-05	0.000114	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTP1—prostate cancer	1.13e-05	0.000113	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ITPR1—prostate cancer	1.11e-05	0.000112	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.1e-05	0.00011	CbGpPWpGaD
Entacapone—COMT—Metabolism—NOS3—prostate cancer	1.07e-05	0.000107	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TYMS—prostate cancer	1.05e-05	0.000105	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—prostate cancer	1.04e-05	0.000104	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LPL—prostate cancer	1.02e-05	0.000102	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CB—prostate cancer	9.88e-06	9.9e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1A1—prostate cancer	9.86e-06	9.88e-05	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—prostate cancer	9.79e-06	9.81e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ERCC2—prostate cancer	9.78e-06	9.8e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTHFR—prostate cancer	9.19e-06	9.21e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARA—prostate cancer	9.02e-06	9.04e-05	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTEN—prostate cancer	8.54e-06	8.56e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAV1—prostate cancer	8.48e-06	8.5e-05	CbGpPWpGaD
Entacapone—COMT—Metabolism—EP300—prostate cancer	8.14e-06	8.16e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.1e-06	8.12e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CG—prostate cancer	7.72e-06	7.74e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—INS—prostate cancer	7.31e-06	7.33e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CREBBP—prostate cancer	7.16e-06	7.18e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CD—prostate cancer	6.79e-06	6.8e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NOS3—prostate cancer	6.41e-06	6.43e-05	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CA—prostate cancer	6.02e-06	6.04e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CB—prostate cancer	5.92e-06	5.93e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—prostate cancer	5.87e-06	5.88e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTEN—prostate cancer	5.11e-06	5.13e-05	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—prostate cancer	4.92e-06	4.93e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—EP300—prostate cancer	4.88e-06	4.89e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CA—prostate cancer	3.61e-06	3.62e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—prostate cancer	2.95e-06	2.95e-05	CbGpPWpGaD
